U.S Physical Therapy Free Cash Flow 2010-2024 | USPH

U.S Physical Therapy free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
U.S Physical Therapy Annual Free Cash Flow
2024 65.75
2023 72.68
2022 50.29
2021 68.21
2020 92.36
2019 52.26
2018 65.81
2017 49.51
2016 42.85
2015 31.33
2014 36.27
2013 40.62
2012 35.08
2011 29.44
2010 27.77
2009 27.13
U.S Physical Therapy Quarterly Free Cash Flow
2024-12-31 65.75
2024-09-30 48.83
2024-06-30 29.24
2024-03-31 2.58
2023-12-31 72.68
2023-09-30 48.07
2023-06-30 34.26
2023-03-31 9.29
2022-12-31 50.29
2022-09-30 33.95
2022-06-30 22.94
2022-03-31 9.12
2021-12-31 68.21
2021-09-30 54.51
2021-06-30 32.26
2021-03-31 16.07
2020-12-31 92.36
2020-09-30 69.11
2020-06-30 43.73
2020-03-31 13.63
2019-12-31 52.26
2019-09-30 39.10
2019-06-30 23.81
2019-03-31 11.13
2018-12-31 65.81
2018-09-30 48.70
2018-06-30 27.35
2018-03-31 14.13
2017-12-31 49.51
2017-09-30 35.32
2017-06-30 19.01
2017-03-31 12.65
2016-12-31 42.85
2016-09-30 33.42
2016-06-30 27.64
2016-03-31 12.84
2015-12-31 31.33
2015-09-30 24.24
2015-06-30 16.44
2015-03-31 1.61
2014-12-31 36.27
2014-09-30 24.96
2014-06-30 18.96
2014-03-31 2.86
2013-12-31 40.62
2013-09-30 25.85
2013-06-30 18.34
2013-03-31 3.60
2012-12-31 35.08
2012-09-30 26.40
2012-06-30 17.05
2012-03-31 4.28
2011-12-31 29.44
2011-09-30 18.17
2011-06-30 11.36
2011-03-31 4.84
2010-12-31 27.77
2010-09-30 22.01
2010-06-30 11.85
2010-03-31 5.57
2009-12-31 27.13
2009-09-30 21.29
2009-06-30 12.43
2009-03-31 4.88
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.298B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00